84 lines
1.9 KiB
Plaintext
84 lines
1.9 KiB
Plaintext
|
Ado-trastuzumab emtansine (Kadcyla)
|
||
|
|
Afatinib (Gilotrif)
|
||
|
|
Aldesleukin (Proleukin)
|
||
|
|
Alectinib (Alecensa)
|
||
|
|
Alemtuzumab (Campath)
|
||
|
|
Atezolizumab (Tecentriq)
|
||
|
|
Avelumab (Bavencio)
|
||
|
|
Axitinib (Inlyta)
|
||
|
|
Belimumab (Benlysta)
|
||
|
|
Belinostat (Beleodaq)
|
||
|
|
Bevacizumab (Avastin)
|
||
|
|
Blinatumomab (Blincyto)
|
||
|
|
Bortezomib (Velcade)
|
||
|
|
Bosutinib (Bosulif)
|
||
|
|
Brentuximab vedotin (Adcetris)
|
||
|
|
Brigatinib (Alunbrig)
|
||
|
|
Cabozantinib (Cabometyx [tablet], Cometriq [capsule])
|
||
|
|
Canakinumab (Ilaris)
|
||
|
|
Carfilzomib (Kyprolis)
|
||
|
|
Ceritinib (Zykadia)
|
||
|
|
Cetuximab (Erbitux)
|
||
|
|
Cobimetinib (Cotellic)
|
||
|
|
Crizotinib (Xalkori)
|
||
|
|
Dabrafenib (Tafinlar)
|
||
|
|
Daratumumab (Darzalex)
|
||
|
|
Dasatinib (Sprycel)
|
||
|
|
Denosumab (Xgeva)
|
||
|
|
Dinutuximab (Unituxin)
|
||
|
|
Durvalumab (Imfinzi)
|
||
|
|
Elotuzumab (Empliciti)
|
||
|
|
Enasidenib (Idhifa)
|
||
|
|
Erlotinib (Tarceva)
|
||
|
|
Everolimus (Afinitor)
|
||
|
|
Gefitinib (Iressa)
|
||
|
|
Ibritumomab tiuxetan (Zevalin)
|
||
|
|
Ibrutinib (Imbruvica)
|
||
|
|
Idelalisib (Zydelig)
|
||
|
|
Imatinib (Gleevec)
|
||
|
|
Ipilimumab (Yervoy)
|
||
|
|
Ixazomib (Ninlaro)
|
||
|
|
Lapatinib (Tykerb)
|
||
|
|
Lenvatinib (Lenvima)
|
||
|
|
Midostaurin (Rydapt)
|
||
|
|
Necitumumab (Portrazza)
|
||
|
|
Neratinib (Nerlynx)
|
||
|
|
Nilotinib (Tasigna)
|
||
|
|
Niraparib (Zejula)
|
||
|
|
Nivolumab (Opdivo)
|
||
|
|
Obinutuzumab (Gazyva)
|
||
|
|
Ofatumumab (Arzerra, HuMax-CD20)
|
||
|
|
Olaparib (Lynparza)
|
||
|
|
Olaratumab (Lartruvo)
|
||
|
|
Osimertinib (Tagrisso)
|
||
|
|
Palbociclib (Ibrance)
|
||
|
|
Panitumumab (Vectibix)
|
||
|
|
Panobinostat (Farydak)
|
||
|
|
Pazopanib (Votrient)
|
||
|
|
Pembrolizumab (Keytruda)
|
||
|
|
Pertuzumab (Perjeta)
|
||
|
|
Ponatinib (Iclusig)
|
||
|
|
Ramucirumab (Cyramza)
|
||
|
|
Regorafenib (Stivarga)
|
||
|
|
Ribociclib (Kisqali)
|
||
|
|
Rituximab (Rituxan, Mabthera)
|
||
|
|
Rituximab/hyaluronidase human (Rituxan Hycela)
|
||
|
|
Romidepsin (Istodax)
|
||
|
|
Rucaparib (Rubraca)
|
||
|
|
Ruxolitinib (Jakafi)
|
||
|
|
Siltuximab (Sylvant)
|
||
|
|
Sipuleucel-T (Provenge)
|
||
|
|
Sonidegib (Odomzo)
|
||
|
|
Sorafenib (Nexavar)
|
||
|
|
Temsirolimus (Torisel)
|
||
|
|
Tocilizumab (Actemra)
|
||
|
|
Tofacitinib (Xeljanz)
|
||
|
|
Tositumomab (Bexxar)
|
||
|
|
Trametinib (Mekinist)
|
||
|
|
Trastuzumab (Herceptin)
|
||
|
|
Vandetanib (Caprelsa)
|
||
|
|
Vemurafenib (Zelboraf)
|
||
|
|
Venetoclax (Venclexta)
|
||
|
|
Vismodegib (Erivedge)
|
||
|
|
Vorinostat (Zolinza)
|
||
|
|
Ziv-aflibercept (Zaltrap)
|